Dermata Therapeutics (NASDAQ:DRMA – Get Free Report) and Yatsen (NYSE:YSG – Get Free Report) are both small-cap consumer staples companies, but which is the superior stock? Get Dermata Therapeutics alerts:Insider & Institutional Ownership8.7% of Dermata Therapeutics shares are held by institutional investors. Given Dermata Therapeutics’ stronger consensus rating and higher probable upside, research analysts plainly believe Dermata Therapeutics is more favorable than Yatsen. Net Margins Return on Equity Return on Assets Dermata Therapeutics N/A -127.91% -105.05% Yatsen -3.04% -4.54% -3.49%Earnings and ValuationThis table compares Dermata Therapeutics and Yatsen”s top-line revenue, earnings per share and valuation. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.